Jennifer A. Nelson - Nov 22, 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Chief Scientific Officer
Signature
/s/ Jennifer A. Nelson
Stock symbol
OMGA
Transactions as of
Nov 22, 2024
Transactions value $
$0
Form type
4
Date filed
11/26/2024, 06:31 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +110K $0.00 110K Nov 22, 2024 Common Stock 110K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on November 15, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.